Christos Kaskavelis - 11 Jun 2021 Form 4/A - Amendment Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role
CMO
Signature
/s/ Christos Kaskavelis
Issuer symbol
ADN
Transactions as of
11 Jun 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 Apr 2023, 16:47:58 UTC
Date Of Original Report
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADN Common Stock Award $0 +345,794 +18% $0.000000 2,247,502 11 Jun 2021 Direct F1
holding ADN Common Stock 1,802,405 11 Jun 2021 By Nemaland Ltd. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 345,794 restricted stock units that is a contingent right to receive common stock upon vesting granted pursuant to the Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan, dated as of February 4, 2021. The restricted stock units will vest 25% upon each anniversary of February 4, 2021, the vesting commencement date, until the fourth anniversary of the vesting commencement date.
F2 Reflects shares of Issuer's common stock beneficially owned through Nemaland Ltd.

Remarks:

This Form 4A amends and restates Table I of the Form 4 filed June 15, 2021, which inadvertently incorrectly stated the Reporting Person's aggregate shares of common stock owned directly and indirectly following the grant reported on such Form 4.